FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083357419> ?p ?o ?g. }

• W2083357419 endingPage "4757" @default.
• W2083357419 startingPage "4753" @default.
• W2083357419 abstract "Lenalidomide has been linked to myelodysplastic syndrome (MDS) after autotransplants for myeloma. Total therapy trials (TT; TT2(-/+) thalidomide) and TT3 (TT3a with bortezomib, thalidomide; TT3b with additional lenalidomide) offered the opportunity to examine the contribution of these immune-modulatory agents to MDS-associated cytogenetic abnormalities (MDS-CA) and clinical MDS or acute leukemia (clinical MDS/AL). Of 1080 patients with serial cytogenetic studies, MDS-CA occurred in 11% and clinical MDS/AL in 3%. Risk features of MDS-CA included TT3b, age ≥65 years, male gender, levels of β-2-microglobulin >5.5 mg/L, and multiple myeloma relapse. Clinical MDS/AL occurred less frequently in the control arm of TT2 and more often with TT3a and TT3b. Since MDS-CA often antedated clinical disease, periodic cytogenetic monitoring is recommended. Larger CD34 quantities should be collected upfront as the risk of MDS could be reduced by applying higher CD34 doses with transplant. Thus, treatment, host, and myeloma features could be linked to MDS development after therapy for this malignancy. This trial was registered at www.clinicaltrials.gov: TT3A: NCT00081939, TT3B: NCT00572169." @default.
• W2083357419 created "2016-06-24" @default.
• W2083357419 creator A5000879635 @default.
• W2083357419 creator A5003642204 @default.
• W2083357419 creator A5015328438 @default.
• W2083357419 creator A5029123414 @default.
• W2083357419 creator A5030746256 @default.
• W2083357419 creator A5037875006 @default.
• W2083357419 creator A5038021934 @default.
• W2083357419 creator A5039551593 @default.
• W2083357419 creator A5039870327 @default.
• W2083357419 creator A5040237587 @default.
• W2083357419 creator A5043535723 @default.
• W2083357419 creator A5048028937 @default.
• W2083357419 creator A5056045203 @default.
• W2083357419 creator A5058127611 @default.
• W2083357419 creator A5073180479 @default.
• W2083357419 creator A5082847220 @default.
• W2083357419 creator A5083639923 @default.
• W2083357419 creator A5085020317 @default.
• W2083357419 creator A5088441096 @default.
• W2083357419 creator A5090044223 @default.
• W2083357419 date "2013-06-06" @default.
• W2083357419 modified "2023-10-16" @default.
• W2083357419 title "Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma" @default.
• W2083357419 cites W1794151065 @default.
• W2083357419 cites W1980694501 @default.
• W2083357419 cites W1983706317 @default.
• W2083357419 cites W1987390592 @default.
• W2083357419 cites W2004614297 @default.
• W2083357419 cites W2011871138 @default.
• W2083357419 cites W2011957619 @default.
• W2083357419 cites W2023501070 @default.
• W2083357419 cites W2037262941 @default.
• W2083357419 cites W2067697502 @default.
• W2083357419 cites W2080302923 @default.
• W2083357419 cites W2106428050 @default.
• W2083357419 cites W2114217833 @default.
• W2083357419 cites W2125721471 @default.
• W2083357419 cites W2128084036 @default.
• W2083357419 cites W2136373453 @default.
• W2083357419 cites W2407107826 @default.
• W2083357419 cites W4249363328 @default.
• W2083357419 doi "https://doi.org/10.1182/blood-2012-11-466961" @default.
• W2083357419 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3674673" @default.
• W2083357419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23603914" @default.
• W2083357419 hasPublicationYear "2013" @default.
• W2083357419 type Work @default.
• W2083357419 sameAs 2083357419 @default.
• W2083357419 citedByCount "37" @default.
• W2083357419 countsByYear W20833574192013 @default.
• W2083357419 countsByYear W20833574192014 @default.
• W2083357419 countsByYear W20833574192015 @default.
• W2083357419 countsByYear W20833574192016 @default.
• W2083357419 countsByYear W20833574192017 @default.
• W2083357419 countsByYear W20833574192018 @default.
• W2083357419 countsByYear W20833574192019 @default.
• W2083357419 countsByYear W20833574192020 @default.
• W2083357419 countsByYear W20833574192021 @default.
• W2083357419 countsByYear W20833574192022 @default.
• W2083357419 countsByYear W20833574192023 @default.
• W2083357419 crossrefType "journal-article" @default.
• W2083357419 hasAuthorship W2083357419A5000879635 @default.
• W2083357419 hasAuthorship W2083357419A5003642204 @default.
• W2083357419 hasAuthorship W2083357419A5015328438 @default.
• W2083357419 hasAuthorship W2083357419A5029123414 @default.
• W2083357419 hasAuthorship W2083357419A5030746256 @default.
• W2083357419 hasAuthorship W2083357419A5037875006 @default.
• W2083357419 hasAuthorship W2083357419A5038021934 @default.
• W2083357419 hasAuthorship W2083357419A5039551593 @default.
• W2083357419 hasAuthorship W2083357419A5039870327 @default.
• W2083357419 hasAuthorship W2083357419A5040237587 @default.
• W2083357419 hasAuthorship W2083357419A5043535723 @default.
• W2083357419 hasAuthorship W2083357419A5048028937 @default.
• W2083357419 hasAuthorship W2083357419A5056045203 @default.
• W2083357419 hasAuthorship W2083357419A5058127611 @default.
• W2083357419 hasAuthorship W2083357419A5073180479 @default.
• W2083357419 hasAuthorship W2083357419A5082847220 @default.
• W2083357419 hasAuthorship W2083357419A5083639923 @default.
• W2083357419 hasAuthorship W2083357419A5085020317 @default.
• W2083357419 hasAuthorship W2083357419A5088441096 @default.
• W2083357419 hasAuthorship W2083357419A5090044223 @default.
• W2083357419 hasBestOaLocation W20833574191 @default.
• W2083357419 hasConcept C126322002 @default.
• W2083357419 hasConcept C143998085 @default.
• W2083357419 hasConcept C2776063141 @default.
• W2083357419 hasConcept C2776364478 @default.
• W2083357419 hasConcept C2777478702 @default.
• W2083357419 hasConcept C2779609412 @default.
• W2083357419 hasConcept C2780007613 @default.
• W2083357419 hasConcept C2780817109 @default.
• W2083357419 hasConcept C2909984355 @default.
• W2083357419 hasConcept C535046627 @default.
• W2083357419 hasConcept C71924100 @default.
• W2083357419 hasConceptScore W2083357419C126322002 @default.
• W2083357419 hasConceptScore W2083357419C143998085 @default.
• W2083357419 hasConceptScore W2083357419C2776063141 @default.
• W2083357419 hasConceptScore W2083357419C2776364478 @default.

• next